top of page

This site was designed with the

website builder. Create your website today.Start Now

Anti-Xa assays: What is their role today in antithrombotic therapy?

Dr. Ayman Nashashibi, MD
Jun 19, 2019
1 min read

Should clinicians abandon the activated partial thromboplastin time for monitoring heparin therapy in favor of anti-Xa assays?

Recent Posts

Axial Spondyloarthritis: A Case-Based Approach

Axial Spondyloarthritis: A Case-Based Approach

Ensuring Early Diagnosis and Targeting Treatment to Remission in Patients with Rheumatoid Arthritis

Ensuring Early Diagnosis and Targeting Treatment to Remission in Patients with Rheumatoid Arthritis

New Frontiers in Managing Heart Failure

New Frontiers in Managing Heart Failure

Comments

bottom of page